Hamilton Insurance Group, Ltd. (HG) Form 10-Q — Nov 4, 2026
Hamilton Insurance Group reported Q3 2026 net income of $228.2 million, up from $176.4 million a year ago, but net income attributable to common shareholders fell to $81.5 million from $136.2 million as allocations to the Two Sigma Hamilton Fund's non-controlling interest surged to $146.7 million from $40.2 million. Underwriting results deteriorated sharply: the combined ratio rose to 97.3% from 87.8%, driven by $47.1 million of unfavorable prior-year development tied to the Ukraine conflict and one large specialty/property reinsurance loss, while Q3 underwriting income fell to $15.5 million from $64.1 million.
Key figures
- Eps
- Q3 2026 basic $0.82, diluted $0.81; nine months basic $3.62, diluted $3.54
- Revenue
- Q3 2026 net premiums earned $591,274 thousand; total revenues $828,039 thousand
- Net Income
- $228,183 thousand (Q3 2026); $700,018 thousand (nine months)
- Total Debt
- $150,000 thousand outstanding term loan
- Revenue Yoy
- Net premiums earned +13.0% YoY (Q3: $591.3M vs $523.0M); gross premiums written +17.3% ($819.7M vs $698.8M)
- Total Assets
- $10,827,021 thousand
- Cash Position
- $1,184,318 thousand (cash and cash equivalents, 9/30/2026); $1,313,618 thousand including restricted cash
- Gross Proceeds
- 0
- Shares Outstanding
- 66221080
- Roe 9m 2026
- 12.5%
- Tshf return q3 2026
- 6.1% net of fees
- Combined ratio 9m 2026
- 94.1%
- Combined ratio q3 2025
- 87.8%
- Combined ratio q3 2026
- 97.3%
- Dividends paid 9m 2026
- $199,495 thousand
- Underwriting income q3 2026
- $15,527 thousand (vs $64,089 thousand Q3 2025)
- California wildfire reserves
- $43.1 million
- Middle east conflict reserves
- $41.7 million
- Tangible book value per share
- $28.97
- Non controlling interest q3 2026
- $146,727 thousand (vs $40,225 thousand Q3 2025)
- Unfavorable prior year development 9m
- $37.1 million (driven by $47.1M Ukraine conflict development)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.